Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Quinn

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|October 16, 2012
Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survivalAsima Mukhopadhyay, Elizabeth R Plummer, Ahmed Elattar, et al.
The Journal of Pathology|December 23, 2011
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesotheliomaSara Busacca, Michael Sheaff, Kenneth Arthur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapyJennifer E Quinn, Colin R James, Gail E Stewart, et al.
The Journal of Biological Chemistry|May 16, 2002
BRCA1 regulates the interferon gamma-mediated apoptotic responseHeather N Andrews, Paul B Mullan, Stewart McWilliams, et al.
Gynecologic Oncology|May 26, 2005
Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancerEunice L Kwak, Kenneth H Moberg, Doke C R Wahrer, et al.
Nucleic Acids Research|July 19, 2013
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancersNiamh E Buckley, Caoimhe B Nic An tSaoir, Jaine K Blayney, et al.
Breast Cancer Research and Treatment|November 3, 2009
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancerJulia J Gorski, Colin R James, Jennifer E Quinn, et al.
Gynecologic Oncology|September 17, 2011
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancerJudith E Carser, Jennifer E Quinn, Caroline O Michie, et al.
Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.
The Journal of Pathology|June 28, 2011
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancerIan Paul, Kienan I Savage, Jaine K Blayney, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|October 16, 2012
Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survivalAsima Mukhopadhyay, Elizabeth R Plummer, Ahmed Elattar, et al.
The Journal of Pathology|December 23, 2011
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesotheliomaSara Busacca, Michael Sheaff, Kenneth Arthur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapyJennifer E Quinn, Colin R James, Gail E Stewart, et al.
The Journal of Biological Chemistry|May 16, 2002
BRCA1 regulates the interferon gamma-mediated apoptotic responseHeather N Andrews, Paul B Mullan, Stewart McWilliams, et al.
Gynecologic Oncology|May 26, 2005
Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancerEunice L Kwak, Kenneth H Moberg, Doke C R Wahrer, et al.
Nucleic Acids Research|July 19, 2013
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancersNiamh E Buckley, Caoimhe B Nic An tSaoir, Jaine K Blayney, et al.
Breast Cancer Research and Treatment|November 3, 2009
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancerJulia J Gorski, Colin R James, Jennifer E Quinn, et al.
Gynecologic Oncology|September 17, 2011
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancerJudith E Carser, Jennifer E Quinn, Caroline O Michie, et al.
Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.
The Journal of Pathology|June 28, 2011
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancerIan Paul, Kienan I Savage, Jaine K Blayney, et al.
Pageof 3